Cetirizine Hydrochloride Solution
NDC Package 70752-103-06
Package Information
Cetirizine Hydrochloride solution is use only with enclosed dosing cupfind right dose on chart belowmL = milliliteradults and children 6 years and over5 mL or 10 mL once daily depending upon severity of symptoms; do not take more than 10 mL in 24 hours. adults 65 years and over 5 mL once daily; do not take more than 5 mL in 24 hours.children 2 to under 6 years of age 2.5 mL once daily. This formulation utilizes a solution delivery system. Marketed by Quagen Pharmaceuticals Llc, this product is identified by NDC 70752-103 and is authorized under FDA application ANDA212266.
Identification & Billing
- RxCUI: 1014673 - cetirizine HCl 5 MG in 5 mL Oral Solution
- RxCUI: 1014673 - cetirizine hydrochloride 1 MG/ML Oral Solution
- RxCUI: 1014673 - cetirizine HCl 1 MG/ML Oral Syrup
- RxCUI: 1014673 - cetirizine HCl 5 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70752 - Quagen Pharmaceuticals Llc
- 70752-103 - Cetirizine Hydrochloride
- 70752-103-06 - 1 BOTTLE, PLASTIC in 1 CARTON / 118 mL in 1 BOTTLE, PLASTIC
- 70752-103 - Cetirizine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70752-103-06 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 118 ml in 1 bottle, plastic of Cetirizine Hydrochloride, a human over the counter drug labeled by Quagen Pharmaceuticals Llc. This solution is formulated for oral use and contains cetirizine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Quagen Pharmaceuticals Llc on October 15, 2022. The current certification is valid through December 31, 2026.
How is this Quagen Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70752010306. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.